245 related articles for article (PubMed ID: 35577777)
1. An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease.
Ghosh P; Katkar GD; Shimizu C; Kim J; Khandelwal S; Tremoulet AH; Kanegaye JT; ; Bocchini J; Das S; Burns JC; Sahoo D
Nat Commun; 2022 May; 13(1):2687. PubMed ID: 35577777
[TBL] [Abstract][Full Text] [Related]
2. An AI-guided signature reveals the nature of the shared proximal pathways of host immune response in MIS-C and Kawasaki disease.
Sahoo D; Katkar GD; Shimizu C; Kim J; Khandelwal S; Tremoulet AH; Kanegaye J; ; Bocchini J; Das S; Burns JC; Ghosh P
bioRxiv; 2021 Aug; ():. PubMed ID: 33880476
[TBL] [Abstract][Full Text] [Related]
3. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
[TBL] [Abstract][Full Text] [Related]
5. Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease.
Bukulmez H
Curr Rheumatol Rep; 2021 Jul; 23(8):58. PubMed ID: 34216296
[TBL] [Abstract][Full Text] [Related]
6. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.
Consiglio CR; Cotugno N; Sardh F; Pou C; Amodio D; Rodriguez L; Tan Z; Zicari S; Ruggiero A; Pascucci GR; Santilli V; Campbell T; Bryceson Y; Eriksson D; Wang J; Marchesi A; Lakshmikanth T; Campana A; Villani A; Rossi P; ; Landegren N; Palma P; Brodin P
Cell; 2020 Nov; 183(4):968-981.e7. PubMed ID: 32966765
[TBL] [Abstract][Full Text] [Related]
7. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection.
Berardicurti O; Conforti A; Ruscitti P; Cipriani P; Giacomelli R
Expert Rev Clin Immunol; 2020 Dec; 16(12):1205-1215. PubMed ID: 33152254
[No Abstract] [Full Text] [Related]
8. A machine-learning algorithm for diagnosis of multisystem inflammatory syndrome in children and Kawasaki disease in the USA: a retrospective model development and validation study.
Lam JY; Shimizu C; Tremoulet AH; Bainto E; Roberts SC; Sivilay N; Gardiner MA; Kanegaye JT; Hogan AH; Salazar JC; Mohandas S; Szmuszkovicz JR; Mahanta S; Dionne A; Newburger JW; Ansusinha E; DeBiasi RL; Hao S; Ling XB; Cohen HJ; Nemati S; Burns JC; ;
Lancet Digit Health; 2022 Oct; 4(10):e717-e726. PubMed ID: 36150781
[TBL] [Abstract][Full Text] [Related]
9. Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases.
Ebina-Shibuya R; Namkoong H; Shibuya Y; Horita N
Int J Infect Dis; 2020 Aug; 97():371-373. PubMed ID: 32553716
[TBL] [Abstract][Full Text] [Related]
10. Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.
Hsieh LE; Grifoni A; Sidney J; Shimizu C; Shike H; Ramchandar N; Moreno E; Tremoulet AH; Burns JC; Franco A
Eur J Immunol; 2022 Jan; 52(1):123-137. PubMed ID: 34599760
[TBL] [Abstract][Full Text] [Related]
11. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors.
Yang CA; Huang YL; Chiang BL
J Formos Med Assoc; 2022 Mar; 121(3):623-632. PubMed ID: 34193364
[TBL] [Abstract][Full Text] [Related]
12. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children.
Porritt RA; Binek A; Paschold L; Rivas MN; McArdle A; Yonker LM; Alter G; Chandnani HK; Lopez M; Fasano A; Van Eyk JE; Binder M; Arditi M
J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34437303
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
Sancho-Shimizu V; Brodin P; Cobat A; Biggs CM; Toubiana J; Lucas CL; Henrickson SE; Belot A; ; Tangye SG; Milner JD; Levin M; Abel L; Bogunovic D; Casanova JL; Zhang SY
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33904890
[TBL] [Abstract][Full Text] [Related]
14. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Meta-Analysis of Neutrophil Activation in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Reveals Potential Shared Immunological Drivers.
Beltran JVB; Lin FP; Chang CL; Ko TM
Circulation; 2023 Nov; 148(22):1778-1796. PubMed ID: 37905415
[TBL] [Abstract][Full Text] [Related]
16. Kawasaki disease shock syndrome in the COVID-19 pandemic.
Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
[TBL] [Abstract][Full Text] [Related]
17. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
[TBL] [Abstract][Full Text] [Related]
18. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?
Santaniello M; Matucci-Cerinic C; Natoli V; Trincianti C; Ridella F; Ravelli A
Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):102-104. PubMed ID: 35080303
[TBL] [Abstract][Full Text] [Related]
19. Biologic disease-modifying antirheumatic drugs to treat multisystem inflammatory syndrome in children.
Cron RQ
Curr Opin Rheumatol; 2022 Sep; 34(5):274-279. PubMed ID: 35791863
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children.
Beckmann ND; Comella PH; Cheng E; Lepow L; Beckmann AG; Tyler SR; Mouskas K; Simons NW; Hoffman GE; Francoeur NJ; Del Valle DM; Kang G; Do A; Moya E; Wilkins L; Le Berichel J; Chang C; Marvin R; Calorossi S; Lansky A; Walker L; Yi N; Yu A; Chung J; Hartnett M; Eaton M; Hatem S; Jamal H; Akyatan A; Tabachnikova A; Liharska LE; Cotter L; Fennessy B; Vaid A; Barturen G; Shah H; Wang YC; Sridhar SH; Soto J; Bose S; Madrid K; Ellis E; Merzier E; Vlachos K; Fishman N; Tin M; Smith M; Xie H; Patel M; Nie K; Argueta K; Harris J; Karekar N; Batchelor C; Lacunza J; Yishak M; Tuballes K; Scott I; Kumar A; Jaladanki S; Agashe C; Thompson R; Clark E; Losic B; Peters L; ; Roussos P; Zhu J; Wang W; Kasarskis A; Glicksberg BS; Nadkarni G; Bogunovic D; Elaiho C; Gangadharan S; Ofori-Amanfo G; Alesso-Carra K; Onel K; Wilson KM; Argmann C; Bunyavanich S; Alarcón-Riquelme ME; Marron TU; Rahman A; Kim-Schulze S; Gnjatic S; Gelb BD; Merad M; Sebra R; Schadt EE; Charney AW
Nat Commun; 2021 Aug; 12(1):4854. PubMed ID: 34381049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
